Alginate 3D Tissue Screening for Accurate Hormone Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug screening methods fail to accurately mimic the natural tissue structures and hormone responses of patient-derived tissues, leading to inaccurate therapeutic outcomes due to the use of 2D cell lines, 3D spheroids, or animal-derived matrices like Matrigel, which lack reproducibility and induce artificial hormone stimulation.
Innovation Solution
A novel alginate-based 3D ex vivo culture system that maintains tissue microstructures by integrating tissue lysis, mRNA capture, and reverse transcription in one step, preserving hormone receptors and responses without external hormones, and enabling high-throughput transcriptomics-based screening.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If 2D cell lines or 3D spheroids are used for drug screening, then the screening process is simplified, but the natural tissue structure and hormone response are not accurately mimicked
Solution Approach 1:
The patent transitions from 2D cell line cultures to 3D tissue microstructure cultures embedded in alginate hydrogel. This dimensional change preserves the natural three-dimensional architecture of patient-derived tissue microstructures while enabling ex vivo culture, thereby maintaining hormone receptor expression and drug response profiles that are lost in 2D systems.
Solution Approach 2:
The patent changes the culture system parameters by using patient-derived tissue microstructures instead of cell lines, and by embedding them in alginate hydrogel instead of using Matrigel. These parameter changes maintain physiological relevance and hormone responsiveness while enabling standardized ex vivo culture conditions.
2Stability of the object's composition
If Matrigel is used as culture matrix, then tissue structure is maintained, but artificial hormone stimulation is induced
Solution Approach 1:
The patent extracts the essential function of Matrigel (providing structural support and 3D environment) while removing its harmful component (artificial hormone contamination). This is achieved by using alginate hydrogel, a synthetic biomaterial that provides equivalent structural support without containing growth factors or hormones.
Solution Approach 2:
The patent employs alginate, a synthetic and inexpensive biomaterial, as a replacement for expensive and biologically complex Matrigel. Alginate provides the necessary structural support for tissue microstructure culture without the biological variability and hormone contamination inherent in animal-derived matrices.
3Ease of operation
If alginate dissociation step is performed before cell lysis, then reagent access is improved, but mRNA capture efficiency decreases
Solution Approach 1:
The patent performs cell lysis and mRNA capture while the alginate hydrogel structure remains intact, before any dissociation step. This preliminary action ensures that reagents can access cells through the hydrogel matrix and that mRNA is captured efficiently from the lysed cells, avoiding the problem of mRNA loss that occurs when alginate is dissociated first.
Solution Approach 2:
The patent inverts the conventional sequence of operations by performing cell lysis and mRNA capture before alginate dissociation, rather than after. This inversion resolves the contradiction by ensuring mRNA capture efficiency is maintained while still allowing reagent access through the intact hydrogel matrix during the lysis process.
4Reliability
If large tissue samples are used for ex vivo assays, then hormone response analysis is possible, but sample availability is limited
Solution Approach 1:
The patent segments tissue samples into small microstructure units that can be embedded individually in alginate hydrogel wells. This segmentation allows multiple independent assays to be performed from small patient-derived tissue samples, enabling high-throughput hormone response analysis without requiring large tissue volumes.
Solution Approach 2:
The patent uses 3D tissue microstructures embedded in alginate hydrogel, which preserves the natural three-dimensional architecture of patient-derived tissues. This approach maintains hormone receptor expression and drug response profiles while requiring only small tissue samples, unlike traditional ex vivo assays that require large tissue pieces.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method faithfully recapitulates patient tissue hormone and drug responses, allowing for accurate prediction of therapeutic options by maintaining hormone receptor expression and signaling, even in complex tissue microstructures, and overcoming the challenges of alginate's barrier to reagent access.
Implementation Method 1
mixed with natural biomaterial alginate and crosslinked into spheres to provide structural support and mechanical environment for the tissue
Implementation Method 2
After mechanical and enzymatic digestion of a tissue sample from a patient
Implementation Method 3
After mechanical and enzymatic digestion of a tissue sample from a patient
Implementation Method 4
integrating tissue lysis, mRNA capture and reverse transcription in one step
Data Source
Figure 1a
Figure 1b
Figure 1c~1d
AI summary
The present invention relates to a method for analyzing cellular responsiveness to hormones or drags in a tissue sample based on an alginate-based 3D ex vivo culture system for normal and malignant tissue microstructures and uses thereof.